Drug firms' Secret Data Supercharge AI Protein Models

An AI system trained on more than 20,000 protein structures from pharmaceutical companies outperforms AlphaFold-like models that rely only on public data, according to a Nature report by Ewen Callaway published September 14, 2026. The finding indicates that proprietary drug-industry data gives protein-structure prediction models an accuracy edge over public-data-only systems.

Subscribe Sign In | Subscribe Drug firms’ Secret Data Supercharge AI Protein Models Ewen Callaway Nature September 14, 2026 Ousa Chea An AI system trained on more than 20,000 protein structures from pharmaceutical companies outperforms AlphaFold-like models that use only public data. Continue Reading⟶ Related Articles